2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: CDR0000701454, FRE-GERCOR-PEPCOL-C10-1, EU-21115, EUDRACT-2010-020468-39, PHARMAENGINE-FRE-GERCOR-PEPCOL, GERCOR-PEPCOL C10-1, PEPCOL, PHARMAENGINE-FRE-GERCOR-PEPCOL-C10-1, NCT01375816
|